Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Garmin Ltd. (GRMN): A Dividend-Paying Tech Stock Gets New Life

Page 1 of 2

Garmin Ltd. (NASDAQ:GRMN) is finding new life after being added to the S&P 500 Index earlier this week. Garmin is a provider of navigation devices, but is facing stiff competition from mobile phone-based navigation. After coming off a $120 high in 2007 and hitting rock bottom at $15 a share in 2009, Garmin has been searching for its place in the tech world. Garmin is down 60% over the last five years, but has managed to be up 5% year to date (check out the bullish options activity in Garmin shares). Let’s take a look at this stock in more detail.

CITADEL INVESTMENT GROUP

Although sales are expected to be flat for 2012 (2% growth) and 2013 (1% growth), we believe that long-term prosperity will come from rising sales in emerging markets, namely Asia. Additional help will be a result of auto sale gains due to a recovering economy, and an “aging out” of vehicles. Beyond the personal navigation devices, growth will come from the outdoor and fitness segment. This area should get a boost from rising discretionary spending and a boost in health-conscious individuals.

In short, it appears that the true value for Garmin shareholders might not lie in a robust growth road map, but a solid income-generating one. Starting in mid-2011, the GPS company began to display a penchant for giving cash to shareholders. Garmin’s shares now have a dividend yield of 4.2% after boosting their dividend payment by 12.5% earlier this year.

The company also has a solid ability to continue to generate cash. Garmin has nearly $1.4 billion in the green stuff, while its annual dividend payout is still just around $350 million. This cash generating ability comes from the fact that Garmin has no debt and a solid return on equity of 17.5%. Another positive is that Garmin’s payout ratio is only 55%; earnings would have to miss next year’s estimates by over 20% before its payout ratio breached 80%.

R.R. Donnelley & Sons Company (NASDAQ:RRD) is the stock that was kicked out of the S&P 500 Index to make room for Garmin. Donnelley has seen its market value steadily decline – down 40% over the last five years – and is getting bumped down to the S&P 400 Midcap Index. Donnelley has made recent acquisitions to expand beyond its typical segments in an effort to stop its stock’s slide. The global communications company pays an 11% dividend yield and should be able continue these outlays, at least in the interim. Donnelley has over $300 million in cash, and pays out $185 million in annual dividends. Billionaire Ken Griffin – founder of Citadel Investment Group – is one of R.R. Donnelley’s top supporters (check out Ken Griffin’s newest picks).

Garmin has similar exposure to the auto industry as Harman International Industries Inc. (NYSE:HAR). Harman is the audio equipment company that is undergoing similar pressures as Garmin. Harman expects FY2013 revenues to be up 6% after a 16% gain in 2012. This will be driven by a rise in auto sales, which already have a $16 billion order backlog, including recent contracts with Toyota and General Motors. The major headwind for Harman will be a weak global economy, but we believe that its exposure to autos will be the major driver of its expected 15% long-term earnings growth rate.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!